{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:24:14Z","timestamp":1775183054836,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13365-024-01230-x","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T16:03:49Z","timestamp":1729526629000},"page":"556-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate"],"prefix":"10.1007","volume":"30","author":[{"given":"Alexandra","family":"Balshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob A.","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"4","key":"1230_CR6","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/NXI.0000000000001017","volume":"8","author":"MC Anagnostouli","year":"2021","unstructured":"Anagnostouli MC, Velonakis G, Dalakas MC (2021) Aggressive herpes zoster in young patients with multiple sclerosis under Dimethyl Fumarate: significance of CD8+ and natural killer cells. Neurol Neuroimmunol Neuroinflamm 8(4):e1017 Published 2021 May 28. https:\/\/doi.org\/10.1212\/NXI.0000000000001017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1230_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","volume":"71","author":"TC Anderson","year":"2022","unstructured":"Anderson TC, Masters NB, Guo A et al (2022) Use of recombinant zoster vaccine in immunocompromised adults aged \u2a7e19 years: recommendations of the Advisory Committee on Immunization practices\u2014United States, 2022. MMWR Morb Mortal Wkly Rep 71:80\u201384","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1230_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jamaneurol.2014.3065","volume":"72","author":"AM Arvin","year":"2015","unstructured":"Arvin AM, Wolinsky JS, Kappos L et al (2015) Varicella-Zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol 72(1):31\u201339. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3065","journal-title":"JAMA Neurol"},{"issue":"11\u201312","key":"1230_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1177\/13524585231189641","volume":"29","author":"A Balshi","year":"2023","unstructured":"Balshi A, Saart E, Pandeya S, Dempsey J, Baber U, Sloane JA (2023) High CD4+:CD8\u2009+\u2009ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate. Mult Scler 29(11\u201312):1465\u20131470. https:\/\/doi.org\/10.1177\/13524585231189641","journal-title":"Mult Scler"},{"key":"1230_CR2","doi-asserted-by":"publisher","unstructured":"Balshi A, Manning N, Dempsey J, Kumbar S, Baber U, Sloane JA (2024) Altered lymphocyte profiles and herpes zoster infections in patients with multiple sclerosis on natalizumab. Mult Scler. Published Online June 16. https:\/\/doi.org\/10.1177\/13524585241260537","DOI":"10.1177\/13524585241260537"},{"issue":"5","key":"1230_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/13524585211037909","volume":"28","author":"R Gold","year":"2022","unstructured":"Gold R, Arnold DL, Bar-Or A et al (2022) Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: final ENDORSE study results. Mult Scler 28(5):801\u2013816. https:\/\/doi.org\/10.1177\/13524585211037909","journal-title":"Mult Scler"},{"issue":"2","key":"1230_CR5","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1212\/NXI.0000000000000203","volume":"3","author":"BB Ma","year":"2016","unstructured":"Ma BB, Ostrow LW, Newsome SD (2016) Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 3(2):e203 Published 2016 Mar 9. https:\/\/doi.org\/10.1212\/NXI.0000000000000203","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"1230_CR1","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1212\/NXI.0000000000000076","volume":"2","author":"CM Spencer","year":"2015","unstructured":"Spencer CM, Crabtree-Hartman EC, Lehmann-Horn K, Cree BA, Zamvil SS (2015) Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 2(3):e76 Published 2015 Feb 12. https:\/\/doi.org\/10.1212\/NXI.0000000000000076","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1230_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/82_2010_31","volume":"342","author":"A Weinberg","year":"2010","unstructured":"Weinberg A, Levin MJ (2010) VZV T cell-mediated immunity. Curr Top Microbiol Immunol 342:341\u2013357. https:\/\/doi.org\/10.1007\/82_2010_31","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-024-01230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-024-01230-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-024-01230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T21:04:19Z","timestamp":1740258259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-024-01230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":9,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1007\/s13365-024-01230-x","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}